1. Home
  2. CWD vs ADXN Comparison

CWD vs ADXN Comparison

Compare CWD & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CaliberCos Inc.

CWD

CaliberCos Inc.

HOLD

Current Price

$1.68

Market Cap

10.8M

Sector

Finance

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$8.10

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWD
ADXN
Founded
2009
2002
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
10.0M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
CWD
ADXN
Price
$1.68
$8.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.5K
8.1K
Earning Date
11-13-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,657,000.00
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
$26.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$6.51
52 Week High
$48.00
$12.05

Technical Indicators

Market Signals
Indicator
CWD
ADXN
Relative Strength Index (RSI) 27.61 47.77
Support Level $1.69 $7.12
Resistance Level $1.83 $8.49
Average True Range (ATR) 0.14 0.58
MACD 0.02 0.01
Stochastic Oscillator 4.35 52.40

Price Performance

Historical Comparison
CWD
ADXN

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: